mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer

mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer

The objective response rate to neoadjuvant chemotherapy (NAC) in patients with non-small cell lung cancer (NSCLC) is approximately 16 %. Therefore, the search for new predictive factors and markers that could precisely predict the NAC response and be relevant to the choice of the adequate treatment...

Full description

Bibliographic Details
Main Authors: M. M. Tsyganov, I. V. Deryusheva, E. O. Rodionov, L. A. Efteev, S. V. Miller, M. K. Ibragimova, E. E. Perminova, O. V. Cheremisina, I. G. Frolova, S. A. Tuzikov, N. V. Litviakov
Format: Article
Language:Russian
Published: Tomsk National Research Medical Center of the Russian Academy of Sciences 2019-02-01
Series:Sibirskij Onkologičeskij Žurnal
Subjects:
non-small cell lung cancer
neoadjuvant chemotherapy
response to chemotherapy
chemosensitivity genes
gene expression
Online Access:https://www.siboncoj.ru/jour/article/view/951

Internet

https://www.siboncoj.ru/jour/article/view/951

Similar Items